RxDoctor Payments Data

Cynthia Williams, MD

Internal Medicine · Houston, TXNPI 1013994508

Payments from drug & device makers

$1,637in general payments, 2019–2025

Across 91 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$278
  • Lilly USA, LLC$151
  • AstraZeneca$129
  • Novo Nordisk$116
  • Novartis$108
  • Bayer$104
  • plus $750 from 27 others

What the payments were for

  • Food & beverage$1,637100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,637 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas

Medicare billing

Part B allowed, 2024
$178,412
Medicare patients
346
Services billed
6,400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban99$66,547
JardianceEmpagliflozin93$61,123
OzempicSemaglutide45$51,170
Repatha SureclickEvolocumab60$36,970
MyrbetriqMirabegron35$26,141
XareltoRivaroxaban17$20,929
EntrestoSacubitril/Valsartan18$17,667
TrulicityDulaglutide12$13,496
JanuviaSitagliptin Phosphate14$11,966
Praluent PenAlirocumab24$11,538
MultaqDronedarone Hcl13$10,310
SynthroidLevothyroxine Sodium85$8,776
SymbicortBudesonide/Formoterol Fumarate18$5,663
Rosuvastatin Calcium320$4,056
Nebivolol Hcl84$4,011

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin, Paxlovid$61$71,711143 claims
Novo NordiskOzempic$116$51,17045 claims
Astellas Pharma US IncMyrbetriq$70$26,14135 claims
Johnson & JohnsonXarelto$41$20,92917 claims
NovartisEntresto$108$17,66718 claims
Lilly USA, LLCTrulicity$151$13,49612 claims
MerckJanuvia$41$11,96614 claims
AbbVieSynthroid, Armour Thyroid$32$11,071100 claims
Sanofi-aventis U.S. LLCMultaq$15$10,31013 claims
AstraZenecaSymbicort$129$5,66318 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$3,972310 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,675 internal medicine providers in Texas.

Other internal medicine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →